Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (381-390 of 406) with videos related to

Pageof 41
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.
The Journal of Pediatrics|April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort StudyStefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recoveryFrederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Annals of Surgery|July 1, 2014
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical StudyRachel Rosenthal, Benjamin Kasenda, Salome Dell-Kuster, et al.
The Cochrane Database of Systematic Reviews|October 13, 2017
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Yannick Wirz, Ramon Sager, et al.
Critical Care Medicine|October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort StudyStefan Schandelmaier, Erik von Elm, John J You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2015
Planning and reporting of quality-of-life outcomes in cancer trialsS Schandelmaier, K Conen, E von Elm, et al.
The Lancet. Infectious Diseases|October 18, 2017
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysisPhilipp Schuetz, Yannick Wirz, Ramon Sager, et al.
Pageof 41

Showing results (381-390 of 406) with videos related to

Sort By:
Pageof 41
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.
The Journal of Pediatrics|April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort StudyStefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recoveryFrederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Annals of Surgery|July 1, 2014
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical StudyRachel Rosenthal, Benjamin Kasenda, Salome Dell-Kuster, et al.
The Cochrane Database of Systematic Reviews|October 13, 2017
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Yannick Wirz, Ramon Sager, et al.
Critical Care Medicine|October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort StudyStefan Schandelmaier, Erik von Elm, John J You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2015
Planning and reporting of quality-of-life outcomes in cancer trialsS Schandelmaier, K Conen, E von Elm, et al.
The Lancet. Infectious Diseases|October 18, 2017
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysisPhilipp Schuetz, Yannick Wirz, Ramon Sager, et al.
Pageof 41